DELCATH SYSTEMS, INC.

Develops targeted chemotherapy delivery systems for treating primary and metastatic liver cancers.

DCTH | NDAQ

Overview

Corporate Details

ISIN(s):: US24661P8077
LEI:
Country:: United States of America
Address:: 566 QUEENSBURY AVENUE, 12804 QUEENSBURY
Website:: https://delcath.com/
Sector:: Manufacturing
Industry:: Manufacture of medical and dental instruments and supplies

Description

Delcath Systems, Inc. is a commercial-stage, interventional oncology company focused on treating primary and metastatic liver cancers. The company develops and commercializes specialty pharmaceutical and medical device products based on its proprietary percutaneous hepatic perfusion (PHP) technology. This minimally-invasive procedure is designed to deliver high-dose chemotherapy directly to the liver while controlling systemic side effects. Its flagship products are the HEPZATO KIT™, recently FDA-approved in the U.S. for treating metastatic uveal melanoma, and the CHEMOSAT® Hepatic Delivery System, a medical device available in Europe. Delcath aims to provide targeted, minimally-invasive treatment options for patients with liver-dominant cancers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all DELCATH SYSTEMS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DELCATH SYSTEMS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for DELCATH SYSTEMS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cytosorbents Corp Specializing in blood purification therapies for critical care to treat life-threatening conditions.	United States of America	CTSO
DAIHAN SCIENTIFIC CO., Ltd Global provider of lab & medical solutions, from manufacturing to total care services.	South Korea	131220
DAIKEN MEDICAL CO.,LTD Develops medical devices for anesthesia, infection control, and aspiration systems globally.	Japan	7775
DANAHER CORP /DE/ Develops biotech, life sciences, and diagnostics tech for healthcare and research markets.	United States of America	DHR
Danish Aerospace Company A/S Develops advanced medical and exercise equipment for astronauts and space applications.	Denmark	DAC
DarioHealth Corp. A digital therapeutics platform using smart devices and coaching for chronic condition management.	United States of America	DRIO
DATASEA INC. Develops acoustic tech and AI data platforms for healthcare, industrial, and agricultural sectors.	United States of America	DTSS
DAXOR CORP Develops an FDA-cleared Blood Volume Analysis system for precise fluid management in hospitals.	United States of America	DXR
Demant A global leader in hearing aids, diagnostics, and care for professionals and end-users.	Denmark	DEMANT
DENTIS CO.,LTD Develops dental implants, medical LED lighting, and CAD/CAM solutions for medical professionals.	South Korea	261200